Cargando…

Intestinal fatty acid-binding protein, a biomarker of intestinal barrier dysfunction, increases with the progression of type 2 diabetes

OBJECTIVE: To investigate serum intestinal fatty acid-binding protein (I-FABP) in two groups of patients with different duration of hyperglycemia in a cross-sectional study. MATERIALS AND METHODS: In the present study, a total of 280 individuals (158 outpatients and 122 inpatients) suffering from hy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yifeng, Ding, Licheng, Yang, Jiayue, Liu, Lijun, Dong, Liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2021
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7863777/ https://www.ncbi.nlm.nih.gov/pubmed/33604184 http://dx.doi.org/10.7717/peerj.10800

Ejemplares similares

Intestinal Fatty Acid Binding Protein, a Biomarker of Intestinal Barrier, is Associated with Severity of Psoriasis
por: Sikora, Mariusz, et al.
Publicado: (2019)

Intestinal fatty acid‐binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability
por: Zhang, Lulu, et al.
Publicado: (2020)

Effects of intestinal flora on polycystic ovary syndrome
por: Liu, Jiayue, et al.
Publicado: (2023)

Seabuckthorn polysaccharide combined with astragalus polysaccharide ameliorate alcoholic fatty liver by regulating intestinal flora
por: Liu, Jiayue, et al.
Publicado: (2022)

Grifola frondosa may play an anti-obesity role by affecting intestinal microbiota to increase the production of short-chain fatty acids
por: Hu, Ruxiao
Publicado: (2023)

Maternal sitagliptin treatment attenuates offspring glucose metabolism and intestinal proinflammatory cytokines IL-6 and TNF-α expression in male rats
por: Zhang, Qian, et al.
Publicado: (2020)

A combined association of serum uric acid, alanine aminotransferase and waist circumference with non-alcoholic fatty liver disease: a community-based study
por: Wang, Min, et al.
Publicado: (2022)

Fatty liver index and progression to type 2 diabetes: a 5-year longitudinal study in Spanish workers with pre-diabetes
por: Busquets-Cortés, Carla, et al.
Publicado: (2021)

Hypercalcemia in a Patient Diagnosed with a Vasoactive Intestinal Peptide Tumor
por: Ataallah, Basma, et al.
Publicado: (2020)

Association between uric acid lowering and renal function progression: a longitudinal study
por: Liu, Liyi, et al.
Publicado: (2021)

Impaired Intestinal Barrier and Tissue Bacteria: Pathomechanisms for Metabolic Diseases
por: Massier, Lucas, et al.
Publicado: (2021)

Combination therapy of anabolic agents and bisphosphonates on bone mineral density in patients with osteoporosis: a meta-analysis of randomised controlled trials
por: Lou, Shenghan, et al.
Publicado: (2018)

Vasoactive Intestinal Peptide Tumor as the Cause of Persistent Diarrhea: A Diagnostic Challenge
por: Lopes, Sara, et al.
Publicado: (2022)

Intestinal fatty acid-binding protein as a biomarker for the diagnosis of strangulated intestinal obstruction: A meta-analysis
por: Wu, Caihong, et al.
Publicado: (2021)

Food-Derived Hemorphins Cross Intestinal and Blood–Brain Barriers In Vitro
por: Domenger, Dorothée, et al.
Publicado: (2018)

Orexin-A Prevents Lipopolysaccharide-Induced Neuroinflammation at the Level of the Intestinal Barrier
por: Tunisi, Lea, et al.
Publicado: (2019)

An Unusual Case of Thyroid Storm Masquerading as an Intestinal Obstruction in a Patient With Malrotation of the Gut
por: Bashir, Khalid, et al.
Publicado: (2021)

Diagnostic accuracy of adrenal imaging for subtype diagnosis in primary aldosteronism: systematic review and meta-analysis
por: Zhou, Yaqiong, et al.
Publicado: (2020)

The intestinal fatty acid-binding protein as a marker for intestinal damage in gastroschisis
por: Kokesova, Alena, et al.
Publicado: (2019)

Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases
por: Shi, Linsen, et al.
Publicado: (2023)

Polyphenol-rich Trapa quadrispinosa pericarp extract ameliorates high-fat diet induced non-alcoholic fatty liver disease by regulating lipid metabolism and insulin resistance in mice
por: Jian, Tunyu, et al.
Publicado: (2019)

Deoxycholic Acid Modulates Cell-Junction Gene Expression and Increases Intestinal Barrier Dysfunction
por: Zeng, Huawei, et al.
Publicado: (2022)

Intestinal fatty acid‐binding protein is a biomarker for diagnosis of biliary tract infection
por: Weng, Yu‐Chieh, et al.
Publicado: (2021)

Qualitative study of barriers to clinical trial retention in adults with recently diagnosed type 1 diabetes
por: Henshall, Catherine, et al.
Publicado: (2018)

Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus
por: Min, Qiuxia, et al.
Publicado: (2022)

Fatty liver predicts the risk for cardiovascular events in middle-aged population: a population-based cohort study
por: Pisto, Pauliina, et al.
Publicado: (2014)

Berberine Slows the Progression of Prediabetes to Diabetes in Zucker Diabetic Fatty Rats by Enhancing Intestinal Secretion of Glucagon-Like Peptide-2 and Improving the Gut Microbiota
por: Wang, Ying, et al.
Publicado: (2021)

Intestinal Barrier Function and Immune Homeostasis Are Missing Links in Obesity and Type 2 Diabetes Development
por: Riedel, Sylvia, et al.
Publicado: (2022)

Decoding the Pathophysiology of Non-alcoholic Fatty Liver Disease Progressing to Non-alcoholic Steatohepatitis: A Systematic Review
por: Yaqub, Sayma, et al.
Publicado: (2021)

The impact of vestibular dysfunction on falls and postural instability in individuals with type 2 diabetes with and without diabetic polyneuropathy
por: Jørgensen, Ina Ejsing Hunnerup, et al.
Publicado: (2023)

Effect of the EndoBarrier Gastrointestinal Liner on obesity and type 2 diabetes: protocol for systematic review and meta-analysis of clinical studies
por: Rohde, Ulrich, et al.
Publicado: (2013)

Recruiting historically under-represented individuals into Project ECHO Diabetes: using barrier analysis to understand disparities in clinical research in the USA
por: Addala, Ananta, et al.
Publicado: (2023)

Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study
por: Huang, Ya-Ping, et al.
Publicado: (2021)

Study protocol to develop a core outcome set for thyroid dysfunction to bridge the unmet needs of patient-centred care
por: Ooi, Cheow Peng, et al.
Publicado: (2021)

Perceived barriers to leisure time physical activity in adults with type 2 diabetes attending primary healthcare in Oman: a cross-sectional survey
por: Alghafri, Thamra, et al.
Publicado: (2017)

‘Is Insulin Right for Me?’ Development of a theory-informed, web-based resource for reducing psychological barriers to insulin therapy in type 2 diabetes
por: Holloway, Edith E, et al.
Publicado: (2021)

Barriers and facilitators of diabetes management by continuous glucose monitoring systems among adults with type 2 diabetes: a protocol of qualitative systematic review
por: Zheng, Mingyue, et al.
Publicado: (2021)

Fufang Zhenzhu Tiaozhi Capsule Prevents Intestinal Inflammation and Barrier Disruption in Mice With Non-Alcoholic Steatohepatitis
por: Lan, Tian, et al.
Publicado: (2022)

Commentary: Intestinal barrier function and immune homeostasis are missing links in obesity and type 2 diabetes development
por: Wang, Yi-feng, et al.
Publicado: (2022)

A glucagon-like peptide-1 analog, liraglutide, ameliorates endothelial dysfunction through miRNAs to inhibit apoptosis in rats
por: Zhang, Qian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7emgq48lrk6mc9mqpff60bo8s5